Anavex Life Sciences Corp (OTCMKTS:AVXL) reported that the CEO and President Christopher U. Missling, PhD, will participate at the upcoming Ladenburg Thalmann Healthcare Conference on September 29, 2015 to be held in New York City. The management intends to plan one-on-one meetings with investment community members’ at the conference.
Recently, Anavex Life reported that it engaged Dr. Harald Hampel, PhD to its Scientific Advisory Board. He is an internationally known expert I field of Alzheimer’s disease and other neurodegenerative diseases. He us a professor as well as AXA Research Fund Chair at Marie Curie University and reputed Sorbonne Universities’ Pierre situated in Paris.
The chair profile is held within the world famous ‘Institute for Memory & Alzheimer’s Disease.’ It is a reference center for neurodegenerative diseases and Alzheimer’s disease. It is affiliated with the Brain and Spine Institute and the known ‘Pitié-Salpétrière University’ Hospital.
Anavex CEO said that they are delighted to have Dr. Hampel in Scientific Advisory Board. Dr. Hampel has been a part of fifty clinical trials during his tenure of 20 years and is renowned in industry as a leading researcher. He has worked on various plans for the development of biomarkers and treatment for AD. Anavex reported that they intend to enhance the detection of the fatal disease at the preclinical stage, which often goes unnoticed.
It is the time when patient do not shows any clinical symptoms or signs of suffering from Alzheimer’s disease. Dr. Hampel’s knowledge and experience in the relevant sector with focus on early diagnosis complements company’s therapeutic approach.
In last trading session, the stock price of Anavex declined gained more than 3% to close the week at $1.29. The gains came at a share volume of 1.50 million compared to monthly average share volume of 2.49 million. After the recent gain, the market cap of Anavex stands at $155.38 million.
After 3 consecutive days of minor losses, Anavex Life Sciences Corp (OTCMKTS:AVXL) enjoyed a positive day as it finished the last trading session of the week with a solid gain of 3.20%. The volume of 1.5 million for the day failed to get higher than the daily average of 1.8 million though and that was a clear indication of the corrective nature f the price action. As the chart attached clearly shows, there is a contraction phase going on in the extreme short term. That contraction of volatility and price is expected to end soon, triggering a trending move in the short term.